Adrenaline can restart the heart, but is no good for the brain

Area of Science:

• Emergency medicine
• Cardiology
• Clinical trials

Background:

• Out-of-hospital cardiac arrest (OHCA) has a low survival rate.
• Epinephrine (adrenaline) is commonly used in advanced cardiac life support for OHCA.
• The effectiveness of epinephrine on neurological outcomes in OHCA remains debated.

Purpose of the Study:

• To determine the effect of early epinephrine administration on survival and neurological outcomes in patients with OHCA.
• To compare the efficacy of epinephrine versus placebo in the pre-hospital setting for cardiac arrest.

Main Methods:

• A randomized, double-blind, placebo-controlled trial was conducted.
• The study involved patients experiencing OHCA who received advanced life support.
• Participants were randomly assigned to receive either epinephrine or a placebo.

Main Results:

• Epinephrine administration resulted in a higher rate of return of spontaneous circulation (ROSC) and survival to hospital discharge compared to placebo.
• However, there was no significant difference in the proportion of patients with favorable neurological function (defined by CPC score) at 30 days.
• The rate of survival with severe neurological impairment was higher in the epinephrine group.

Conclusions:

• Epinephrine improves survival rates in OHCA patients but does not enhance neurological recovery.
• The use of epinephrine in OHCA may lead to more survivors with severe brain damage.
• Further research is needed to optimize resuscitation strategies for OHCA, balancing return of circulation with neurological protection.